IR502

DB06463Experimental

IR502 (Zorcell) is a potential treatment for psoriasis.

Primary indication
Investigated for use/treatment in psoriasis and psoriatic disorders.Curator reviewed
Code names
IR502

Which companies are running trials of IR502, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In